2017 专家共识报告:难治性甲状腺功能减退的诊断和治疗

2017-07-10 国外内分泌相关专家小组(统称) J Endocrinol Invest. 2017 Jul 10.

经常有甲状腺功能减退的患者对标准激素替代治疗不敏感而额外需要大剂量左旋甲状腺素,本文主要针对难治性甲状腺功能减退的诊断和治疗等内容提出基本管理原则和策略。

中文标题:

2017 专家共识报告:难治性甲状腺功能减退的诊断和治疗

英文标题:

Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

发布日期:

2017-07-10

简要介绍:

经常有甲状腺功能减退的患者对标准激素替代治疗不敏感而额外需要大剂量左旋甲状腺素,本文主要针对难治性甲状腺功能减退的诊断和治疗等内容提出基本管理原则和策略。

 

拓展指南:甲状腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 专家共识报告:难治性甲状腺功能减退的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=96cb01c001a856b9, title=2017 专家共识报告:难治性甲状腺功能减退的诊断和治疗, enTitle=Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report., guiderFrom=J Endocrinol Invest. 2017 Jul 10., authorId=null, author=, summary=经常有甲状腺功能减退的患者对标准激素替代治疗不敏感而额外需要大剂量左旋甲状腺素,本文主要针对难治性甲状腺功能减退的诊断和治疗等内容提出基本管理原则和策略。 , cover=, journalId=null, articlesId=null, associationId=949, associationName=国外内分泌相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jul 10 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>经常有甲状腺功能减退的患者对标准激素替代治疗不敏感而额外需要大剂量左旋甲状腺素,本文主要针对难治性甲状腺功能减退的诊断和治疗等内容提出基本管理原则和策略。 </P> <P> </P>拓展指南:<strong>与<font color=red>甲状腺</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=5f7471c001a84089" title="甲状腺疾病检验诊断报告模式专家共识" target=_blank>甲状腺疾病检验诊断报告模式专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=faa231c001ae70c4" title="成人甲状腺功能减退症诊治指南" target=_blank>成人甲状腺功能减退症诊治指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9e1b41c001ae6141" title="NCCN临床实践指南:甲状腺癌(2017.V1)" target=_blank>NCCN临床实践指南:甲状腺癌(2017.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f60181c001ae367c" title="中国垂体促甲状腺激素腺瘤诊治专家共识(2017)" target=_blank>中国垂体促甲状腺激素腺瘤诊治专家共识(2017)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5c6921c001a49559" title="2017 法国分化型甲状腺癌放射性碘治疗,分子成像和血清标志物检查指南" target=_blank>2017 法国分化型甲状腺癌放射性碘治疗,分子成像和血清标志物检查指南</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA" target=_blank>有关甲状腺更多指南</a></ul>, tagList=[TagDto(tagId=3468, tagName=甲状腺功能减退)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4690, appHits=485, showAppHits=6, pcHits=3294, showPcHits=1285, likes=179, shares=12, comments=2, approvalStatus=1, publishedTime=Sun Aug 20 21:16:08 CST 2017, publishedTimeString=2017-07-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 20 21:16:08 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:10:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 专家共识报告:难治性甲状腺功能减退的诊断和治疗)])
2017 专家共识报告:难治性甲状腺功能减退的诊断和治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=252521, encodeId=fa562525214d, content=太好了,正是我想要的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a25a2170520, createdName=新1794, createdTime=Fri Oct 13 11:09:17 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236320, encodeId=f41023632084, content=学习了.谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56012097942, createdName=清风清茶, createdTime=Wed Aug 23 09:26:20 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-10-13 新1794

    太好了,正是我想要的!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=252521, encodeId=fa562525214d, content=太好了,正是我想要的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a25a2170520, createdName=新1794, createdTime=Fri Oct 13 11:09:17 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236320, encodeId=f41023632084, content=学习了.谢谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56012097942, createdName=清风清茶, createdTime=Wed Aug 23 09:26:20 CST 2017, time=2017-08-23, status=1, ipAttribution=)]
    2017-08-23 清风清茶

    学习了.谢谢!

    0